Is chemoimmunotherapy maintenance of value in patients with chronic lymphocytic leukaemia and minimal residual disease?

Lancet Haematol. 2019 Sep;6(9):e441-e442. doi: 10.1016/S2352-3026(19)30107-3. Epub 2019 Jul 16.

Author

Affiliation

¹ Internal Medicine and Center of Integrated Oncology Cologne-Bonn, University Hospital of Cologne, Cologne, 50937, Germany. Electronic address: anna-maria.fink@uk-koeln.de.

PMID: 31324601
DOI: 10.1016/S2352-3026(19)30107-3

No abstract available

Publication types

Comment

MeSH terms

Adenine / analogs & derivatives
Antibodies, Monoclonal, Humanized
Humans
Leukemia, Lymphocytic, Chronic, B-Cell*
Neoplasm, Residual
Piperidines
Pyrazoles
Pyrimidines

Substances

Antibodies, Monoclonal, Humanized
Piperidines
Pyrazoles
Pyrimidines
ibrutinib
Adenine
obinutuzumab